SAN FRANCISCO, March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025 ...

CowboysCountry.com broke the story of the Cowboys being “very close’ to a done deal with Osa. And now we have done-deal details. FRISCO - The Dallas Cowboys are starting to open their wallets ...

Most knew it would happen, and so it has turned out to be true: Osa Odighizuwa has signed a four-year, $80 million deal with the Dallas Cowboys. Seen as a crucial part of the defensive line under ...

WASHINGTON (AP) — The Department of Veterans Affairs is planning a reorganization that includes cutting over 80,000 jobs from the sprawling agency that provides health care for retired military ...

The Division of Student Affairs offers a variety of awards, recognitions, and a scholarship to current students who have demonstrated outstanding contributions to the areas of student leadership, ...

Where the World and UD Come Together. The Global and Intercultural Affairs Center (GIA Center) imagines a community of empowered global citizens building a just, peaceful, and sustainable world. Our ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. President Donald Trump’s first month in office has been dizzying for U.S ...

Credit: zorukis/Shutterstock. Nektar Therapeutics has concluded target enrolment in the Phase IIb REZOLVE-AA trial of its investigational biologic therapy, rezpegaldesleukin, for treating individuals ...

SAN FRANCISCO - Nektar Therapeutics (NASDAQ:NKTR), currently trading at $0.87 with a market capitalization of $162.5 million, announced today that it has achieved target enrollment for its Phase 2b ...